We also stratified our recruited CRC patients into subgroups according to the pathological stage, and results indicated that high MAOB expression remained significantly correlated with a poor prognosis in patients with late stage (stage III + IV; p = 0.008 for OS and p = 0.024 for DFS) (Figure S1A, lower panel). The gene discussed is MAOB; the disease is colorectal carcinoma.